Taiwan Semiconductor Manufacturing ( TSM 2.02%) is currently a $1.14 trillion stock. So, for it to reach $2 trillion by 2030, it would need to rise by 75% over the next five years, delivering an 11% ...

Apple ( NASDAQ: AAPL ), Qualcomm ( NASDAQ: QCOM) and MediaTek are likely to launch 2nm system-on-a-chips in the latter part ...

Initiation of the FALCON-HD trial follows promising Phase 1 results demonstrating up to 72% reduction in HTT mRNA in healthy volunteers The SKY-0515 Phase 1 trial in patients with Huntington's disease ...

Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small molecule drug targeting early-stage Alzheimer's disease (AD). TML-6 combines ...

Rakuten Medical Announces Trial in Progress Poster Presentation at ASCO 2025 and Enrollment Expansion to Taiwan for Global Phase 3 ASP-1929-381 News provided by Rakuten Medical, Inc.

Poster presentation to highlight the ongoing global Phase 3 ASP-1929-381 study at ASCO 2025Global patient enrollment continues, with Taiwan now actively enrolling following the U.S., and Japan ...

In 2024, the company successfully optimized its 2PIC solution to support systems up to 100 kW in a 24U chassis. Now, AEWIN is proud to become the first company in Taiwan to offer a fully integrated 2P ...

KALOS and LOGOS are replicate confirmatory, randomized, double-blind, double-dummy, parallel group, multi-centre, 24-to-52-week variable length Phase III trials to assess the efficacy and safety ...

The Taipower Offshore Wind Farm Phase 2 offshore wind farm is being developed by TPC, also known as Taipower, about 20km off the coast of Changhua County, Taiwan. The company completed the 109.2MW TPC ...

Taiwan Semiconductor Manufacturing Company Limited (TSM)’s share was trading at $177.10 as of March 7 th. TSM’s trailing and forward P/E were 25.74 and 19.92 respectively according to Yahoo ...

We recently compiled a list of the 10 AI News That Broke The Internet. In this article, we are going to take a look at where Lantern Pharma Inc. (NASDAQ:LTRN) stands against the other AI stocks.